Management of Recurrent Infusion Reactions

Immediate Management

• The European Society for Medical Oncology (ESMO) guidelines recommend stopping the infusion immediately and administering aggressive symptomatic treatment, including diphenhydramine 25-50 mg IV and famotidine 50 mg IV, for a patient who reacts again after restarting at half rate 1, 2
• Methylprednisolone 1-2 mg/kg IV can be given every 6 hours, equivalent to 100-200 mg for a typical adult, as part of the symptomatic treatment 1

Critical Decision Point: Rechallenge vs. Discontinuation

• The ESMO guidelines explicitly state that rechallenge in reactions with CTCAE severity Grade 3 or higher should not be attempted, and a patient who reacts twice is demonstrating escalating severity that suggests true hypersensitivity rather than a simple infusion rate issue 1

Signs for Permanent Discontinuation

• Bronchospasm or significant dyspnea, severe hypotension requiring vasopressors, angioedema, full body rash with pruritus, and any cardiovascular instability are signs that the infusion should be permanently discontinued 1, 3, 4

Rechallenge Considerations

• If rechallenge is absolutely necessary, premedicate with higher-dose corticosteroids, such as methylprednisolone 100 mg IV given 30-60 minutes before the next infusion, and consider using an even slower rate than the half-rate that failed 2

Common Pitfalls to Avoid

• Do not restart at full rate, and do not use corticosteroids alone without antihistamines, as combination therapy is essential 1, 3, 4
• Monitor continuously for 24 hours after a severe reaction, as biphasic reactions can occur 1